Aamir Khakwani

Also affiliated with Clinical Research Institute, Novartis (United Kingdom)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer”.

Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer

The Breast(2025)10.1016/j.breast.2025.104437

N/A

0.373DataRank · unranked

11 citations

Sara M. Tolaney, Denise A. Yardley, Lowell Hart, Pedram Razavi, Peter A. Fasching +9 more

Treatment Patterns and Outcomes of Patients With Myelodysplastic Syndrome (MDS) by IPSS‐R Scores at Academic Cancer Centers

Advances in Hematology(2025)10.1155/ah/9924808

N/A

0DataRank · unranked

2 citations

Andre Hejazi, Vonetta L. Williams, Craig Comperatore, Srinivas K. Tantravahi, Najla Al Ali +14 more